Putnam New York Investment Grade Municipal Trust PMN 深沪

已收盘 08-22 16:00:00 美东时间

0.5359

-0.013

-2.39%

华盛通

立即下载

最高0.5577
今开0.5577
成交量 36.10万股
最低 0.5172
昨收 0.549
总市值 1751.81万
52周最高 1.59
市盈率 ^静 5.10
换手率 1.10%
52周最低 0.38
委比 32.01%
总股本 3268.92万
历史最高 9.80
量比 0.92
振幅 7.38%
历史最低 0.38
每手 1
风险率 0.26%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

ProMIS Neurosciences Announces At The Market Offering

ProMIS Neurosciences ( ($PMN) ) has issued an announcement. On August 13, 2025,...

08-20 04:56
Phoenix Mecano Faces Temporary Sales Decline Amid Tariff Conflicts

Phoenix Mecano AG ( ($CH:PMN) ) has shared an update. Phoenix Mecano reported a...

08-19 13:38
ProMIS Neurosciences Files For Mixed Shelf Of Up To $50M

- SEC Filing

08-14 04:38
ProMIS Neurosciences GAAP EPS of -$0.29

ProMIS Neurosciences press release (NASDAQ:PMN): Q2 GAAP EPS of -$0.29. Cash and cash equivalents were $4.5 million as of June 30, 2025, compared to $1.0 million as of June 30, 2024. More on ProMIS ...

08-13 22:27
ProMIS Neurosciences Q2 EPS $(0.29) Misses $(0.17) Estimate

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.17) by 65.71 percent. This is a 123.08 percent decrease over losses of $(0.13) per share

08-13 19:15
ProMIS Neurosciences To Present PRECISE-AD Trial And EpiSelect Platform At AAIC 2025

Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310Posters highlighting PRECISE-AD, the Company's Phase 1b clinical trial design and optimization of

07-29 20:19
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

ProMIS Neurosciences announced its invitation to present at the 2025 Alzheimer's Association International Conference (AAIC) in Toronto. The Company will showcase its ongoing PRECISE-AD Phase 1b clinical trial evaluating PMN310, a novel therapeutic targeting toxic amyloid-beta oligomers in Alzheimer's Disease (AD). PMN310 is designed to avoid ARIA risks and potentially improve safety and efficacy compared to existing therapies. The presentation w...

07-29 12:00
ProMIS Neurosciences Announces $3M PIPE Offering

ProMIS Neurosciences ( ($PMN) ) has shared an update. On July 28, 2025, ProMIS ...

07-28 19:56
泰柬士兵在边境争议地区交火，发生了什么？

泰柬外交关系一夜“降级”，边境争议地区“擦枪走火”。发生了什么？

07-24 11:57
ProMIS Neurosciences Announces $3.2M Fundraising Initiatives

An announcement from ProMIS Neurosciences ( ($PMN) ) is now available. On July ...

07-23 05:06

派息除权日	每股总股息	派息日期
2007-05-22	0.04	2007-06-01
2007-04-20	0.04	2007-05-01
2007-03-21	0.04	2007-04-02
2007-02-16	0.04	2007-03-01
2007-01-22	0.04	2007-02-01
2006-12-20	0.05	2007-01-02
2006-11-21	0.04	2006-12-01
2006-10-20	0.04	2006-11-01
2006-09-20	0.04	2006-10-02
2006-08-21	0.04	2006-09-01
2006-07-20	0.04	2006-08-01
2006-06-21	0.04	2006-07-03
2006-05-22	0.04	2006-06-01
2006-04-20	0.04	2006-05-01
2006-03-22	0.04	2006-04-03
2006-02-16	0.04	2006-03-01
2006-01-20	0.04	2006-02-01
2005-12-20	0.04	2006-01-03
2005-11-21	0.04	2005-12-01
2005-10-20	0.04	2005-11-01
2005-09-21	0.04	2005-10-03
2005-08-22	0.04	2005-09-01
2005-07-20	0.04	2005-08-01
2005-06-22	0.04	2005-07-01
2005-05-20	0.05	2005-06-01
2005-04-20	0.05	2005-05-02
2005-03-22	0.05	2005-04-01
2005-02-18	0.05	2005-03-01
2005-01-20	0.05	2005-02-01
2004-12-21	0.06	2005-01-03
2004-11-22	0.06	2004-12-01
2004-10-20	0.06	2004-11-01
2004-09-22	0.06	2004-10-01
2004-08-20	0.06	2004-09-01
2004-07-21	0.06	2004-08-02
2004-06-22	0.06	2004-07-01
2004-05-20	0.06	2004-06-01
2004-04-21	0.06	2004-05-03
2004-03-22	0.06	2004-04-01
2004-02-20	0.06	2004-03-01
2004-01-21	0.06	2004-02-02
2003-12-22	0.06	2004-01-02
2003-11-20	0.06	2003-12-01
2003-10-22	0.06	2003-11-03
2003-09-22	0.06	2003-10-01
2003-08-20	0.06	2003-09-02
2003-07-22	0.06	2003-08-01
2003-06-20	0.06	2003-07-01
2003-05-21	0.06	2003-06-02
2003-04-22	0.06	2003-05-01
2003-03-20	0.06	2003-04-01
2003-02-20	0.06	2003-03-03
2003-01-16	0.06	2003-02-03
2002-12-18	0.07	2003-01-02
2002-11-18	0.06	2002-12-02
2002-10-17	0.06	2002-11-01
2002-09-18	0.06	2002-10-01
2002-08-16	0.06	2002-09-03
2002-07-18	0.06	2002-08-01
2002-06-18	0.06	2002-07-01
2002-05-16	0.06	2002-06-03
2002-04-18	0.06	2002-05-01
2002-03-18	0.06	2002-04-01
2002-01-17	0.06	2002-02-01
2001-12-18	0.06	2002-01-02
2001-11-16	0.06	2001-12-03
2001-10-18	0.06	2001-11-01
2001-09-18	0.06	2001-10-01
2001-08-16	0.06	2001-09-04
2001-07-18	0.06	2001-08-01
2001-06-18	0.06	2001-07-02
2001-05-17	0.06	2001-06-01
2001-04-18	0.06	2001-05-01
2001-03-16	0.06	2001-04-02
2001-02-15	0.06	2001-03-01
2001-01-18	0.06	2001-02-01
2000-12-18	0.07	2001-01-02
2000-11-16	0.07	2000-12-01
2000-10-18	0.07	2000-11-01
2000-09-18	0.07	2000-10-02
2000-08-17	0.07	2000-09-01
2000-07-18	0.07	2000-08-01
2000-06-16	0.07	2000-07-03
2000-05-18	0.07	2000-06-01
2000-04-18	0.07	2000-05-01
2000-03-16	0.07	2000-04-03
2000-02-17	0.07	2000-03-01
2000-01-18	0.07	2000-02-01
1999-12-16	0.07	2000-01-03
1999-11-18	0.07	1999-12-01
1999-10-18	0.07	1999-11-01
1999-09-16	0.07	1999-10-01
1999-08-18	0.07	1999-09-01
1999-07-16	0.07	1999-08-02
1999-06-17	0.07	1999-07-01
1999-05-18	0.07	1999-06-01
1999-04-16	0.07	1999-05-03
1999-03-18	0.07	1999-04-01
1999-02-18	0.07	1999-03-01
1999-01-15	0.07	1999-02-01
1998-12-17	0.07	1999-01-04
1998-11-18	0.07	1998-12-01
1998-10-16	0.07	1998-11-02
1998-09-17	0.07	1998-10-01
1998-08-18	0.07	1998-09-01
1998-07-16	0.07	1998-08-03
1998-06-18	0.07	1998-07-01
1998-05-18	0.07	1998-06-01
1998-04-16	0.07	1998-05-01
1998-03-18	0.07	1998-04-01
1998-02-18	0.07	1998-03-02
1998-01-15	0.07	1998-02-02
1997-12-18	0.07	1998-01-02
1997-11-18	0.07	1997-12-01
1997-10-16	0.07	1997-11-03
1997-09-18	0.07	1997-10-01
1997-08-18	0.07	1997-09-02
1997-07-17	0.07	1997-08-01
1997-06-18	0.07	1997-07-01
1997-05-16	0.07	1997-06-02
1997-04-17	0.07	1997-05-01
1997-03-18	0.07	1997-04-01
1997-02-18	0.07	1997-03-03
1997-01-15	0.07	1997-02-03
1996-12-18	0.07	1997-01-02
1996-11-18	0.07	1996-12-02
1996-10-17	0.07	1996-11-01
1996-09-18	0.07	1996-10-01
1996-08-16	0.07	1996-09-03
1996-07-18	0.07	1996-08-01
1996-06-18	0.07	1996-07-01
1996-05-16	0.07	1996-06-03
1996-04-18	0.07	1996-05-01
1996-03-18	0.07	1996-04-01
1996-02-15	0.07	1996-03-01
1996-01-18	0.07	1996-02-01
1995-12-18	0.07	1996-01-02
1995-11-16	0.08	1995-12-01
1995-10-18	0.08	1995-11-01
1995-09-18	0.08	1995-10-02
1995-08-17	0.08	1995-09-01
1995-07-19	0.08	1995-08-01
1995-06-16	0.08	1995-07-03
1995-05-16	0.08	1995-06-01
1995-04-13	0.08	1995-05-01
1995-03-14	0.08	1995-04-03
1995-02-14	0.08	1995-03-01
1995-01-13	0.08	1995-02-01
1994-12-14	0.17	1995-01-03
1994-11-15	0.08	1994-12-01
1994-10-14	0.08	1994-11-01
1994-09-14	0.08	1994-10-03
1994-08-16	0.08	1994-09-01
1994-07-14	0.08	1994-08-01
1994-06-14	0.08	1994-07-01
1994-05-16	0.08	1994-06-01
1994-04-14	0.08	1994-05-02
1994-03-15	0.08	1994-04-04
1994-02-15	0.08	1994-03-01
1994-01-13	0.08	1994-02-01
1993-12-14	0.23	1994-01-03
1993-11-16	0.08	1993-12-01
1993-10-14	0.08	1993-11-01
1993-09-14	0.08	1993-10-01
1993-08-16	0.08	1993-09-01
1993-07-14	0.08	1993-08-02
1993-06-15	0.08	1993-07-01
1993-05-14	0.08	1993-06-01
1993-04-14	0.08	1993-05-03
1993-03-16	0.08	1993-04-01
1993-02-16	0.08	1993-03-01
1993-01-13	0.08	1993-02-01

公司名称	ProMIS Neurosciences, Inc.
行业分类	Biotechnology
业务描述	ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Putnam New York Investment Grade Municipal Trust PMN 深 沪

0.5359

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Putnam New York Investment Grade Municipal Trust PMN 深沪